Private Advisor Group LLC boosted its position in Enovix Co. (NASDAQ:ENVX – Free Report) by 23.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 99,900 shares of the company’s stock after purchasing an additional 19,056 shares during the period. Private Advisor Group LLC owned about 0.06% of Enovix worth $933,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Blue Trust Inc. lifted its stake in Enovix by 102.1% in the 2nd quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock valued at $29,000 after purchasing an additional 957 shares during the last quarter. GAMMA Investing LLC lifted its stake in Enovix by 11,176.2% in the 2nd quarter. GAMMA Investing LLC now owns 2,368 shares of the company’s stock valued at $37,000 after purchasing an additional 2,347 shares during the last quarter. Strategic Investment Solutions Inc. IL acquired a new stake in Enovix in the 2nd quarter valued at about $39,000. Beacon Capital Management LLC lifted its stake in Enovix by 71.9% in the 1st quarter. Beacon Capital Management LLC now owns 4,298 shares of the company’s stock valued at $34,000 after purchasing an additional 1,798 shares during the last quarter. Finally, Voisard Asset Management Group Inc. lifted its stake in Enovix by 25.0% in the 2nd quarter. Voisard Asset Management Group Inc. now owns 5,000 shares of the company’s stock valued at $77,000 after purchasing an additional 1,000 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Price Performance
ENVX stock opened at $9.04 on Friday. The company’s fifty day simple moving average is $10.03 and its 200 day simple moving average is $11.07. Enovix Co. has a 12-month low of $5.70 and a 12-month high of $18.68. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of -5.61 and a beta of 1.98. The company has a quick ratio of 3.84, a current ratio of 3.98 and a debt-to-equity ratio of 0.97.
Analyst Upgrades and Downgrades
ENVX has been the subject of several research reports. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Wednesday. TD Cowen raised their price objective on shares of Enovix from $11.00 to $14.00 and gave the stock a “hold” rating in a research report on Thursday, August 1st. Piper Sandler restated an “overweight” rating and set a $19.00 price objective (down from $23.00) on shares of Enovix in a research report on Monday, August 5th. Finally, Oppenheimer restated an “outperform” rating and set a $36.00 price objective on shares of Enovix in a research report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.50.
Check Out Our Latest Research Report on Enovix
Insider Activity
In other news, insider Arthi Chakravarthy sold 35,000 shares of the company’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $13.00, for a total transaction of $455,000.00. Following the transaction, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 15.70% of the company’s stock.
Enovix Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also
- Five stocks we like better than Enovix
- Profitably Trade Stocks at 52-Week Highs
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Basic Materials Stocks Investing
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Stock Dividend Cuts Happen Are You Ready?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.